← Leaderboards
Omer Tolga Inan
Georgia Institute Of Technology
$7,275,823
Attributed
$12,325,978
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,325,978 · 5
By mechanism
UH3$5,776,792 · 1
R01$5,088,540 · 2
UG3$844,223 · 1
R56$616,423 · 1
Top collaborators
- James Douglas Bremner6 shared
- Liviu Klein6 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Farrokh Ayazi$162,570
- Woon-Hong Yeo$2,870,531
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyResolutionBaseSymptomsCardiovascular SystemResponseMeasurementAffectHospitalsAlgorithmsDiagnosisAmericanPhysiologicalSensorDesignSignal TransductionPhysiologyOperative Surgical ProceduresQuality Of LifeFeedbackDevicesSurfaceProgramsPhotoplethysmography
Grant awards (19)
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders$1,912,347
UH3 · FY2025 · DA
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders$1,912,347
UH3 · FY2024 · DA
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders$1,952,098
UH3 · FY2023 · DA
Non invasive vagal nerve stimulation in opioid use disorders$90,990
UG3 · FY2021 · DA
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders$13,728
UG3 · FY2021 · DA
Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders$739,505
UG3 · FY2020 · DA
Non-invasive biosensors to detect cardiovascular changes in heart failure$567,696
R01 · FY2020 · HL · contact PI
Wearable lung sounds, fluid, and body temperature monitoring for patients with COVID-19$396,542
R01 · FY2020 · EB · contact PI
SCH: INT: Wearable knee Joint Health Sensing Using Acoustical Emissions$72,254
R01 · FY2020 · EB · contact PI
Non-invasive biosensors to detect cardiovascular changes in heart failure$578,379
R01 · FY2019 · HL · contact PI
SCH: INT: Wearable knee Joint Health Sensing Using Acoustical Emissions$413,767
R01 · FY2019 · EB · contact PI
SCH: INT: Wearable knee Joint Health Sensing Using Acoustical Emissions$50,103
R01 · FY2019 · EB · contact PI
Non-invasive biosensors to detect cardiovascular changes in heart failure$567,685
R01 · FY2018 · HL · contact PI
SCH: INT: Wearable knee Joint Health Sensing Using Acoustical Emissions$414,051
R01 · FY2018 · EB · contact PI
Non-invasive biosensors to detect cardiovascular changes in heart failure$567,625
R01 · FY2017 · HL · contact PI
SCH: INT: Wearable knee Joint Health Sensing Using Acoustical Emissions$422,574
R01 · FY2017 · EB · contact PI
Non-invasive biosensors to detect cardiovascular changes in heart failure$581,487
R01 · FY2016 · HL · contact PI
SCH: INT: Wearable knee Joint Health Sensing Using Acoustical Emissions$456,377
R01 · FY2016 · EB · contact PI
Wearable Cardiomechanics Monitor to Decrease Heart Failure Readmissions$616,423
R56 · FY2015 · AG · contact PI